Baseline Productions

BSSP · OTC

$0.00+$0.00 (+0.00%)TodayMarket closed · Oct 20, 1:15 PM ET

Prev close $0.00

About BSSP

Bassline Productions, Inc. develops mobile based hardware and software based products. The company is headquartered in Scottsdale, Arizona. The company went IPO on 2011-09-28. The firm is focused on commercialization of its proteins for the treatment of cancer and various infectious diseases. Its Irreversible Pepsin Fraction (IPF) is a therapeutic platform technology that can be used to facilitate a range of applications. IPF turns on the immune system to fight autoimmune diseases. IPF binds to thymus (T)-cells and turns on T helper cell type 1 (Th1) immune system responses that kill infected cells. The firm's lead compound is a suspension of IPF, which is indicated for the treatment of autoimmune diseases, such as cancer, cirrhosis and Hepatitis C. The Company's product, IMMUNE-THERAPEUTIC PROTEIN (ITP), is a therapeutic protein isolated from porsine pepsin, which is irreversible, modified, and fractionate to the sequence IPF.

Employees: 0
Headquarters: Scottsdale, Arizona
Listed: Sep 28, 2011
Sector: Health Care
Industry: Biotechnology

Similar companies

Companies in the same industry as Baseline Productions

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.